posted on 2012-10-24, 09:03authored byC. I. Jones, L. A. Moraes, W. J. Kaiser, J. M. Gibbins, S. F. Garner, A. Rankin, W. H. Ouwehand, A. H. Goodall
Platelet endothelial cell adhesion molecule-1 (PECAM-1) inhibits platelet response to collagen and may also inhibit two other major platelet agonists ADP and thrombin although this has been less well explored. We hypothesized that the combined effect of inhibiting these three platelet activating pathways may act to significantly inhibit thrombus formation. We demonstrate a negative relationship between PECAM-1 surface expression and platelet response to cross-linked collagen related peptide (CRP-XL) and ADP, and an inhibitory effect of PECAM-1 clustering on platelet response to CRP-XL, ADP and thrombin. This combined inhibition of multiple signaling pathways results in a marked reduction in thrombus formation.
History
Citation
FEBS Letters, 2009, 583 (22), pp. 3618-3624
Version
VoR (Version of Record)
Published in
FEBS Letters
Publisher
Wiley, Federation of European Biochemical Societies